{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:45:09Z","timestamp":1791812709428,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/06397\/2025"],"award-info":[{"award-number":["UID\/06397\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Biological determinants of bone turnover in chronic kidney disease (CKD) remain incompletely understood. Although albuminuria is an established marker of kidney damage and predictor of renal and cardiovascular outcomes, its relationship with bone remodeling, as assessed by quantitative bone histomorphometry, has not previously been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a cross-sectional study of 56 adults with CKD stages 3\u20134 who underwent transiliac bone biopsy with quantitative histomorphometry following double tetracycline labeling. Associations between 24-h urinary albumin excretion and individual bone histomorphometric parameters were evaluated using multivariable linear regression. Models were adjusted for age, sex, estimated glomerular filtration rate (eGFR), intact parathyroid hormone (iPTH), and fibroblast growth factor 23 (FGF23).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In multivariable analyses, higher 24-h urinary albumin excretion was associated with a histomorphometric pattern consistent with increased bone turnover, reflected by greater bone formation and cell surface indices. Specifically, log\u2081\u2080-transformed urinary albumin excretion was associated with higher bone formation rate (B\u00a0=\u00a00.295, 95% CI 0.088 to 0.501; P\u00a0=\u00a00.008), osteoblast surface (B\u00a0=\u00a00.588, 95% CI 0.187 to 0.988; P\u00a0=\u00a00.005) and osteoclast surface (B\u00a0=\u00a00.464, 95% CI 0.041 to 0.887; P\u00a0=\u00a00.033). Associations with mineralization-related parameters and bone volume were not statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with CKD stages 3\u20134, higher urinary albumin excretion was independently associated with quantitative histomorphometric indices of higher bone turnover. These findings suggest that albuminuria may mark a bone remodeling phenotype not fully captured by eGFR, iPTH, and FGF23. Larger prospective studies are needed to define the biological basis and clinical implications of this association.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag346","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:45:25Z","timestamp":1790855125000},"source":"Crossref","is-referenced-by-count":0,"title":["Albuminuria is associated with higher turnover-related bone histomorphometric indices in chronic kidney disease stages 3\u20134"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6144-0179","authenticated-orcid":false,"given":"Ricardo","family":"Neto","sequence":"first","affiliation":[{"name":"RISE-Health, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Department of Medicine, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Department of Nephrology, ULS S\u00e3o Jo\u00e3o , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Fernandes","sequence":"additional","affiliation":[{"name":"RISE-Health, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Department of Nephrology, ULS S\u00e3o Jo\u00e3o , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"USF Barcel Sa\u00fade, ULS Barcelos\/Esposende , Barcelos ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Alencastre","sequence":"additional","affiliation":[{"name":"RISE-Health, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Department of Medicine, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Fraz\u00e3o","sequence":"additional","affiliation":[{"name":"RISE-Health, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Department of Medicine, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Department of Nephrology, ULS S\u00e3o Jo\u00e3o , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026101208471679900_bib1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2026101208471679900_bib2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5414\/cnp70296","article-title":"Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3\u20135","volume":"70","author":"Lehmann","year":"2008","journal-title":"Clin Nephrol"},{"key":"2026101208471679900_bib3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5935\/0101-2800.20140042","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J Bras Nefrol"},{"key":"2026101208471679900_bib4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int"},{"key":"2026101208471679900_bib5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40620-017-0397-7","article-title":"Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease","volume":"30","author":"Massy","year":"2017","journal-title":"J Nephrol"},{"key":"2026101208471679900_bib6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"2026101208471679900_bib7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int"},{"key":"2026101208471679900_bib8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2215\/CJN.06640712","article-title":"Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures","volume":"8","author":"Barzilay","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101208471679900_bib9","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.ekir.2023.08.016","article-title":"Degree of albuminuria is associated with increased risk of fragility fractures independent of estimated GFR","volume":"8","author":"Cooke-Hubley","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026101208471679900_bib10","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026101208471679900_bib11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.10331011","article-title":"FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy","volume":"7","author":"Lundberg","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101208471679900_bib12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11255-012-0163-7","article-title":"Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study","volume":"45","author":"Yap","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"2026101208471679900_bib13","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1681\/ASN.2014010104","article-title":"Proteinuria increases plasma phosphate by altering its tubular handling","volume":"26","author":"de\u00a0Seigneux","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026101208471679900_bib14","doi-asserted-by":"publisher","first-page":"w14509","DOI":"10.4414\/smw.2017.14509","article-title":"On the relationship between proteinuria and plasma phosphate","volume":"147","author":"de\u00a0Seigneux","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"2026101208471679900_bib15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ndt\/gfy119","article-title":"Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease","volume":"34","author":"Oka","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026101208471679900_bib16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ndt\/gfy403","article-title":"The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study","volume":"35","author":"Kim","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2026101208471679900_bib17","doi-asserted-by":"publisher","first-page":"27481","DOI":"10.1038\/s41598-024-79291-5","article-title":"Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)","volume":"14","author":"Shimamoto","year":"2024","journal-title":"Sci Rep"},{"key":"2026101208471679900_bib18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026101208471679900_bib19","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1046\/j.1523-755.1999.00413.x","article-title":"Bone histology in patients with nephrotic syndrome and normal renal function","volume":"55","author":"Mittal","year":"1999","journal-title":"Kidney Int"},{"key":"2026101208471679900_bib20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/sj.ki.5002084","article-title":"Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients","volume":"71","author":"Dias","year":"2007","journal-title":"Kidney Int"},{"key":"2026101208471679900_bib21","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1681\/ASN.2004121062","article-title":"Increased osteoblastic activity and expression of receptor activator of NF-\u03baB ligand in nonuremic nephrotic syndrome","volume":"16","author":"Freundlich","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026101208471679900_bib22","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1093\/ndt\/gfp117","article-title":"Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats","volume":"24","author":"Matsui","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2026101208471679900_bib23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026101208471679900_bib24","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.2215\/CJN.01100307","article-title":"Role of bone biopsy in stages 3 to 4 chronic kidney disease","volume":"3","author":"Gal-Moscovici","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101208471679900_bib25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2026101208471679900_bib26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1053\/j.ajkd.2015.11.028","article-title":"PTH and\/or bone histology: are we still waiting for a verdict from the CKD-MBD grand jury?","volume":"67","author":"Covic","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026101208471679900_bib27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026101208471679900_bib28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11914-017-0362-3","article-title":"Biomarkers predicting bone turnover in the setting of CKD","volume":"15","author":"Evenepoel","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"2026101208471679900_bib29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1681\/ASN.2017050584","article-title":"Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy","volume":"29","author":"Salam","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026101208471679900_bib30","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/ckj\/sfab081","article-title":"Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease stages 3 and 4","volume":"14","author":"Neto","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026101208471679900_bib31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026101208471679900_bib32","first-page":"1","article-title":"KDIGO Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2026101208471679900_bib33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2026101208471679900_bib34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s8756-3282(99)00257-4","article-title":"Normative data for iliac bone histomorphometry in growing children","volume":"26","author":"Glorieux","year":"2000","journal-title":"Bone"},{"key":"2026101208471679900_bib35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00774-007-0778-4","article-title":"Brazilian normal static bone histomorphometry: effects of age, sex, and race","volume":"25","author":"Reis","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"2026101208471679900_bib36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"National Kidney Foundation: K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2026101208471679900_bib37","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archinte.167.13.1379","article-title":"Albuminuria and risk of nonvertebral fractures","volume":"167","author":"J\u00f8rgensen","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026101208471679900_bib38","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/jbmr.3065","article-title":"Association of increased urinary albumin with risk of incident clinical fracture and rate of hip bone loss: the Osteoporotic Fractures in Men Study","volume":"32","author":"Fink","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2026101208471679900_bib39","doi-asserted-by":"publisher","first-page":"e2903","DOI":"10.1210\/clinem\/dgaa317","article-title":"Biomarkers of bone turnover identify subsets of chronic kidney disease patients at higher risk for fracture","volume":"105","author":"Hughes-Austin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101208471679900_bib40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag346\/71559850\/sfag346.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag346\/71559850\/sfag346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag346\/71559850\/sfag346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:47:49Z","timestamp":1791809269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag346\/8859084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag346","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10,1]]},"article-number":"sfag346"}}